Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
|Podcasts|July 30, 2021
Researchers evaluate data on priapism malpractice litigation
Author(s)Urology Times staff
“I think it's the responsibility of the physician to really take on educating and counseling and setting clear expectations and that way, when complications do arise, patients are better equipped, and they have a more favorable outcome,” says Ariana Matz, MD.
Advertisement
In this podcast, Ariana Matz, MD, discusses the Urology study, “Review of priapism litigation in the United States,” for which she served as a study author.
Advertisement
Related to this article
Heather Florio joins to discuss the potential role of supplements in pelvic and sexual health.
Pearls & Perspectives: Expanding Sexual Health Conversations Through Digital Media, With Wendy Brant
Amy Pearlman, MD, and Wendy Brant discuss building a digital audience, navigating sexual health content online, and the role of communication in relationships.
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Key Updates to the AUA NMIBC Guideline, With Peter E. Clark, MD
2
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
3
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
4
Closing Risk Stratification Gaps in Localized Prostate Cancer With AI
5